Income Statement - ALNYLAM PHARMACEUTICALS, INC. (ALNY)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 | Dec-09 | Dec-08 | Dec-07 | Dec-06 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3,713.94 | 2,248.24 | 1,828.29 | 1,037.42 | 844.29 | 492.85 | 219.75 | 74.91 | 89.91 | 47.16 | 41.10 | 50.56 | 47.17 | 66.73 | 82.76 | 100.04 | 100.53 | 96.16 | 50.90 | 26.93 |
| Cost of revenue | 677.17 | 323.37 | 310.41 | 168.82 | 140.14 | 78.05 | 25.06 | 1.80 | 578.10 | 462.15 | 330.41 | 229.78 | 134.19 | 122.87 | 132.45 | 136.98 | 142.65 | 118.40 | 136.19 | 62.62 |
| Gross profit | 3,036.77 | 1,924.87 | 1,517.89 | 868.60 | 704.14 | 414.80 | 194.69 | 73.11 | 89.91 | 47.16 | 41.10 | 50.56 | 47.17 | 66.73 | 82.76 | 100.04 | 100.53 | 96.16 | 50.90 | 26.93 |
| Total operating expenses | 2,535.19 | 2,101.76 | 1,800.06 | 1,653.67 | 1,412.80 | 1,243.24 | 1,134.12 | 887.78 | 590.00 | 471.75 | 337.11 | 234.78 | 140.11 | 131.18 | 137.58 | 144.11 | 148.64 | 124.00 | 144.07 | 66.43 |
| Operating income | 501.58 | -176.89 | -282.18 | -785.07 | -708.65 | -828.44 | -939.43 | -814.67 | -500.09 | -424.59 | -296.01 | -404.98 | -92.94 | -129.46 | -54.82 | -44.07 | -48.11 | -27.84 | -93.18 | -39.50 |
| Non-operating income (net) | -178.43 | -200.49 | -151.34 | -341.92 | -143.49 | -27.16 | 54.18 | 54.00 | 9.21 | 14.48 | 5.94 | 4.38 | 1.02 | 12.87 | -2.83 | 1.07 | 1.10 | 2.31 | 12.96 | 4.89 |
| Income before tax | 323.15 | -377.38 | -433.52 | -1,126.99 | -852.14 | -855.60 | -885.25 | -760.67 | -490.87 | -410.11 | -290.07 | -400.60 | -91.92 | -116.59 | -57.65 | -43.00 | -47.01 | -25.53 | -80.22 | -34.61 |
| Income tax expense | 9.41 | -99.22 | 6.73 | 4.16 | 0.68 | 2.68 | 0.86 | 0.82 | -25.60 | -23.44 | -24.91 | -40.21 | -2.70 | -10.57 | -5.80 | 0.51 | 0.58 | 0.72 | 5.25 | -4.89 |
| Net income | 313.75 | -278.16 | -440.24 | -1,131.16 | -852.82 | -858.28 | -886.12 | -761.50 | -490.87 | -410.11 | -290.07 | -360.40 | -89.23 | -106.01 | -57.65 | -43.52 | -47.59 | -26.25 | -85.47 | -34.61 |
Show Quarterly Income Statement
Income Statement - ALNYLAM PHARMACEUTICALS, INC. (ALNY)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | Dec-17 | Sep-17 | Jun-17 | Mar-17 | Dec-16 | Sep-16 | Jun-16 | Mar-16 | Dec-15 | Sep-15 | Jun-15 | Mar-15 | Dec-14 | Sep-14 | Jun-14 | Mar-14 | Dec-13 | Sep-13 | Jun-13 | Mar-13 | Dec-12 | Sep-12 | Jun-12 | Mar-12 | Dec-11 | Sep-11 | Jun-11 | Mar-11 | Dec-10 | Sep-10 | Jun-10 | Mar-10 | Dec-09 | Sep-09 | Jun-09 | Mar-09 | Dec-08 | Sep-08 | Jun-08 | Mar-08 | Dec-07 | Sep-07 | Jun-07 | Mar-07 | Dec-06 | Sep-06 | Jun-06 | Mar-06 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,167.18 | 1,097.03 | 1,249.03 | 773.69 | 594.19 | 593.17 | 500.92 | 659.83 | 494.33 | 439.72 | 750.53 | 318.75 | 319.29 | 335.04 | 264.31 | 224.82 | 213.26 | 258.54 | 187.63 | 220.55 | 177.57 | 163.56 | 125.85 | 103.96 | 99.48 | 71.68 | 70.06 | 44.71 | 33.29 | 21.03 | 2.07 | 29.91 | 21.90 | 37.92 | 17.10 | 15.93 | 18.96 | 17.45 | 13.65 | 8.71 | 7.35 | 7.55 | 6.32 | 8.69 | 18.54 | 24.02 | 10.97 | 7.30 | 8.28 | 10.85 | 8.99 | 8.69 | 18.64 | 8.50 | 16.76 | 20.88 | 20.59 | 20.46 | 20.79 | 20.61 | 20.90 | 21.19 | 27.67 | 26.62 | 24.56 | 26.63 | 24.25 | 24.60 | 25.06 | 24.40 | 25.73 | 23.83 | 22.19 | 18.23 | 16.32 | 9.13 | 7.22 | 6.98 | 8.21 | 6.02 | 5.72 |
| Cost of revenue | 211.12 | 267.72 | 197.23 | 142.95 | 71.04 | 102.82 | 85.91 | 68.67 | 65.98 | 85.86 | 84.31 | 85.37 | 54.87 | 51.27 | 41.12 | 40.81 | 35.63 | 37.66 | 32.66 | 38.76 | 31.06 | 23.02 | 21.80 | 19.93 | 13.30 | 12.18 | 5.21 | 4.33 | 3.35 | 1.67 | 0.14 | 220.02 | 166.13 | 181.51 | 139.31 | 133.34 | 122.47 | 129.87 | 116.83 | 97.15 | 112.77 | 94.99 | 79.38 | 76.61 | 67.07 | 66.39 | 53.05 | 53.32 | 50.08 | 37.99 | 38.46 | 27.29 | 26.32 | 29.84 | 32.62 | 30.53 | 25.45 | 32.80 | 31.97 | 32.45 | 35.23 | 32.31 | 32.94 | 37.02 | 34.71 | 33.56 | 32.79 | 45.07 | 31.24 | 30.42 | 27.34 | 35.32 | 25.20 | 20.22 | 62.81 | 23.15 | 30.02 | 15.77 | 14.82 | 31.77 | 0.00 |
| Gross profit | 956.05 | 829.31 | 1,051.80 | 630.74 | 523.15 | 490.35 | 415.01 | 591.15 | 428.36 | 353.86 | 666.22 | 233.38 | 264.42 | 283.77 | 223.19 | 184.01 | 177.63 | 220.87 | 154.97 | 181.80 | 146.50 | 140.54 | 104.06 | 84.03 | 86.17 | 59.51 | 64.85 | 40.39 | 29.95 | 19.37 | 1.93 | 29.91 | 21.90 | 37.92 | 17.10 | 15.93 | 18.96 | 17.45 | 13.65 | 8.71 | 7.35 | 7.55 | 6.32 | 8.69 | 18.54 | 24.02 | 10.97 | 7.30 | 8.28 | 10.85 | 8.99 | 8.69 | 18.64 | 8.50 | 16.76 | 20.88 | 20.59 | 20.46 | 20.79 | 20.61 | 20.90 | 21.19 | 27.67 | 26.62 | 24.56 | 26.63 | 24.25 | 24.60 | 25.06 | 24.40 | 25.73 | 23.83 | 22.19 | 18.23 | 16.32 | 9.13 | 7.22 | 6.98 | 8.21 | 6.02 | 5.72 |
| Total operating expenses | 687.42 | 697.59 | 683.81 | 646.94 | 505.07 | 595.51 | 491.92 | 542.54 | 471.79 | 470.26 | 452.35 | 463.22 | 414.23 | 472.38 | 481.23 | 375.70 | 324.36 | 415.43 | 336.65 | 327.96 | 332.76 | 334.76 | 329.26 | 282.89 | 296.33 | 357.58 | 281.15 | 276.66 | 218.74 | 239.72 | 256.49 | 222.26 | 169.30 | 185.23 | 142.90 | 136.41 | 125.47 | 132.89 | 120.33 | 101.16 | 117.37 | 100.06 | 84.65 | 81.63 | 70.76 | 69.73 | 56.17 | 56.19 | 52.68 | 40.44 | 41.23 | 30.00 | 28.45 | 31.84 | 34.91 | 32.95 | 31.48 | 34.04 | 33.23 | 33.73 | 36.57 | 33.60 | 36.40 | 38.24 | 35.87 | 34.70 | 33.90 | 47.01 | 33.04 | 32.22 | 28.97 | 36.66 | 26.15 | 21.12 | 67.65 | 24.09 | 31.21 | 16.97 | 16.82 | 17.13 | 15.51 |
| Operating income | 268.64 | 131.72 | 367.98 | -16.20 | 18.08 | -105.16 | -76.91 | 48.61 | -43.44 | -116.40 | 213.87 | -229.83 | -149.81 | -188.61 | -258.04 | -191.69 | -146.73 | -194.56 | -181.68 | -146.16 | -186.25 | -194.22 | -225.20 | -198.86 | -210.16 | -298.07 | -216.30 | -236.27 | -188.79 | -220.36 | -254.56 | -192.35 | -147.41 | -147.30 | -125.80 | -120.47 | -106.51 | -115.43 | -106.68 | -92.45 | -110.03 | -92.51 | -78.33 | -72.94 | -52.22 | -45.71 | -45.20 | -45.01 | -269.06 | -29.59 | -32.23 | -21.31 | -9.80 | -88.35 | -18.15 | -12.07 | -10.89 | -13.59 | -12.44 | -13.12 | -15.68 | -12.41 | -8.73 | -11.63 | -11.31 | -8.07 | -9.65 | -22.41 | -7.98 | -7.81 | -3.23 | -12.83 | -3.96 | -2.89 | -51.34 | -14.95 | -23.99 | -9.99 | -8.60 | -11.11 | -9.80 |
| Non-operating income (net) | -46.98 | 29.42 | -129.01 | -19.16 | -59.67 | -88.80 | -31.76 | -59.78 | -20.15 | -21.28 | -63.13 | -44.38 | -22.56 | -18.41 | -147.90 | -82.99 | -92.62 | -65.74 | -22.56 | -42.17 | -13.02 | -49.38 | -27.25 | 20.96 | 28.51 | 21.49 | 7.37 | 17.75 | 7.57 | 9.28 | 9.72 | 28.87 | 6.13 | 5.08 | 2.86 | 2.05 | -0.78 | 2.50 | 2.61 | 2.32 | 7.05 | 1.79 | 1.54 | 1.59 | 1.01 | 2.23 | 1.28 | 0.62 | 0.25 | 0.26 | 0.28 | 0.26 | 0.23 | 15.59 | -1.36 | -0.89 | -0.48 | -0.72 | -0.80 | -0.71 | -0.61 | 5.91 | -0.60 | -3.24 | -1.00 | -0.16 | -0.11 | 0.62 | 0.76 | -1.52 | -0.42 | 1.32 | 2.92 | 4.61 | 3.73 | 2.26 | 2.35 | -24.62 | 1.20 | 1.20 | 0.94 |
| Income before tax | 221.65 | 161.14 | 238.97 | -35.36 | -41.60 | -193.96 | -108.66 | -11.17 | -63.59 | -137.69 | 150.74 | -274.21 | -172.36 | -207.02 | -405.94 | -274.67 | -239.36 | -260.30 | -204.24 | -188.33 | -199.28 | -243.60 | -252.45 | -177.90 | -181.65 | -276.58 | -208.93 | -218.52 | -181.22 | -211.08 | -244.84 | -163.48 | -141.28 | -142.23 | -122.94 | -118.42 | -107.29 | -112.93 | -104.07 | -90.13 | -102.97 | -90.72 | -76.79 | -71.35 | -51.21 | -43.48 | -43.92 | -44.39 | -268.81 | -29.34 | -31.96 | -21.05 | -9.58 | -72.76 | -19.50 | -12.96 | -11.37 | -14.30 | -13.24 | -13.82 | -16.29 | -6.50 | -9.33 | -14.86 | -12.31 | -8.23 | -9.76 | -21.79 | -7.22 | -9.34 | -3.65 | -11.51 | -1.03 | 1.72 | -47.61 | -12.69 | -21.65 | -34.61 | -7.40 | -9.91 | -8.86 |
| Income tax expense | -15.66 | -25.28 | -12.12 | 30.92 | 15.88 | -110.20 | 2.91 | 5.72 | 2.35 | 0.18 | 2.99 | 1.82 | 1.74 | 0.47 | -0.02 | 2.73 | 0.99 | -1.84 | 0.28 | 1.23 | 1.02 | -0.06 | 0.84 | 1.33 | 0.58 | -0.40 | -0.39 | 0.96 | 0.70 | 0.36 | 0.45 | 0.08 | -0.06 | -7.95 | -3.30 | -2.58 | -2.13 | -5.22 | -2.20 | -2.09 | -6.41 | -6.69 | -1.61 | 0.43 | -0.43 | -22.09 | 0.07 | -0.32 | -17.87 | 3.02 | -2.27 | -2.88 | -0.56 | -10.57 | -2.54 | -2.86 | -0.41 | -0.24 | -0.93 | -1.59 | -1.80 | 0.43 | 0.30 | -0.23 | 0.02 | -0.44 | -0.55 | 0.91 | 0.67 | 0.06 | -0.79 | 1.25 | 0.21 | 0.06 | 5.19 | -2.26 | -2.35 | -26.17 | -1.20 | -1.20 | -0.94 |
| Net income | 205.99 | 186.42 | 251.08 | -66.28 | -57.48 | -83.76 | -111.57 | -16.89 | -65.94 | -137.87 | 147.75 | -276.02 | -174.10 | -207.49 | -405.92 | -277.40 | -240.34 | -258.46 | -204.51 | -189.56 | -200.29 | -243.54 | -253.29 | -179.23 | -182.22 | -276.19 | -208.54 | -219.48 | -181.92 | -211.44 | -245.28 | -163.56 | -141.21 | -142.23 | -122.94 | -118.42 | -107.29 | -112.93 | -104.07 | -90.13 | -102.97 | -90.72 | -76.79 | -71.78 | -50.78 | -21.39 | -43.99 | -44.07 | -250.94 | -32.36 | -29.69 | -18.17 | -9.01 | -62.19 | -19.50 | -12.96 | -11.37 | -14.30 | -13.24 | -13.82 | -16.29 | -6.93 | -9.63 | -14.63 | -12.32 | -7.79 | -9.21 | -22.70 | -7.89 | -9.39 | -2.86 | -12.76 | -1.24 | 1.66 | -52.79 | -12.69 | -21.65 | -8.44 | -7.40 | -9.91 | -8.86 |